Type | MGI:General | Description | midfacial hypoplasia treatment with SB203580, a p38 kinase inhibitor, reduces epidermal and skull abnormalities but does not improve the survival of mutants, however, treatment with MEK/ERK inhibitor U0126 has no effect |